Literature DB >> 28103685

An Effective Bacterial Fucosidase for Glycoprotein Remodeling.

Tsung-I Tsai1,2,3, Shiou-Ting Li1, Chiu-Ping Liu1,2, Karen Y Chen1,4, Sachin S Shivatare1, Chin-Wei Lin1, Shih-Fen Liao1, Chih-Wei Lin1, Tsui-Ling Hsu1, Ying-Ta Wu1, Ming-Hung Tsai5, Meng-Yu Lai5, Nan-Horng Lin5, Chung-Yi Wu1, Chi-Huey Wong1,2,3.   

Abstract

Fucose is an important component of many oligo- and polysaccharide structures as well as glycoproteins and glycolipids, which are often associated with a variety of physiological processes ranging from fertilization, embryogenesis, signal transduction, and disease progression, such as rheumatoid arthritis, inflammation, and cancer. The enzyme α-l-fucosidase is involved in the cleavage of the fucosidic bond in glycans and glycoconjugates, particularly the Fuc-α-1,2-Gal, Fuc-α-1,3/4-GlcNAc, and Fuc-α-1,6-GlcNAc linkages. Here, we report a highly efficient fucosidase, designated as BfFucH identified from a library of bacterial glycosidases expressed in E. coli from the CAZy database, which is capable of hydrolyzing the aforementioned fucosidic linkages, especially the α-1,6-linkage from the N-linked Fuc-α-1,6-GlcNAc residue on glycoproteins. Using BfFucH coupled with endoglycosidases and the emerging glycosynthases allows glycoengineering of IgG antibodies to provide homogeneous glycoforms with well-defined glycan structures and optimal effector functions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28103685     DOI: 10.1021/acschembio.6b00821

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  15 in total

Review 1.  Oligosaccharide Synthesis and Translational Innovation.

Authors:  Larissa Krasnova; Chi-Huey Wong
Journal:  J Am Chem Soc       Date:  2019-02-18       Impact factor: 15.419

2.  Chemoenzymatic Defucosylation of Therapeutic Antibodies for Enhanced Effector Functions Using Bacterial α-Fucosidases.

Authors:  Chao Li; Tiezheng Li; Lai-Xi Wang
Journal:  Methods Mol Biol       Date:  2018

3.  Glycoengineering of antibody (Herceptin) through yeast expression and in vitro enzymatic glycosylation.

Authors:  Chiu-Ping Liu; Tsung-I Tsai; Ting Cheng; Vidya S Shivatare; Chung-Yi Wu; Chung-Yi Wu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

4.  Glycan Remodeling of Human Erythropoietin (EPO) Through Combined Mammalian Cell Engineering and Chemoenzymatic Transglycosylation.

Authors:  Qiang Yang; Yanming An; Shilei Zhu; Roushu Zhang; Chun Mun Loke; John F Cipollo; Lai-Xi Wang
Journal:  ACS Chem Biol       Date:  2017-05-05       Impact factor: 5.100

5.  Lectin and Liquid Chromatography-Based Methods for Immunoglobulin (G) Glycosylation Analysis.

Authors:  Tea Petrović; Irena Trbojević-Akmačić
Journal:  Exp Suppl       Date:  2021

Review 6.  Importance and Monitoring of Therapeutic Immunoglobulin G Glycosylation.

Authors:  Yusuke Mimura; Radka Saldova; Yuka Mimura-Kimura; Pauline M Rudd; Roy Jefferis
Journal:  Exp Suppl       Date:  2021

7.  Functional exploration of the GH29 fucosidase family.

Authors:  Hendrik Grootaert; Linde Van Landuyt; Paco Hulpiau; Nico Callewaert
Journal:  Glycobiology       Date:  2020-08-20       Impact factor: 4.313

8.  Identification and characterization of a core fucosidase from the bacterium Elizabethkingia meningoseptica.

Authors:  Tiansheng Li; Mengjie Li; Linlin Hou; Yameng Guo; Lei Wang; Guiqin Sun; Li Chen
Journal:  J Biol Chem       Date:  2017-12-01       Impact factor: 5.157

Review 9.  Enzymatic Synthesis of Glycans and Glycoconjugates.

Authors:  Thomas Rexer; Dominic Laaf; Johannes Gottschalk; Hannes Frohnmeyer; Erdmann Rapp; Lothar Elling
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

10.  Comparative studies on the substrate specificity and defucosylation activity of three α-l-fucosidases using synthetic fucosylated glycopeptides and glycoproteins as substrates.

Authors:  Sunaina Kiran Prabhu; Chao Li; Guanghui Zong; Roushu Zhang; Lai-Xi Wang
Journal:  Bioorg Med Chem       Date:  2021-06-07       Impact factor: 3.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.